AAPL   399.12 (+4.02%)
MSFT   215.45 (+0.83%)
FB   249.19 (+1.68%)
AMZN   3,328.89 (+4.03%)
NVDA   427.95 (+2.09%)
CGC   17.92 (+2.87%)
BABA   260.61 (-0.15%)
MU   51.01 (+0.61%)
TSLA   1,757.84 (+13.80%)
AMD   56.72 (+1.50%)
T   29.83 (-1.00%)
F   6.11 (+0.16%)
DIS   119.68 (+0.28%)
NFLX   569.73 (+3.83%)
BAC   24.00 (-0.08%)
BA   175.46 (-1.67%)
AAPL   399.12 (+4.02%)
MSFT   215.45 (+0.83%)
FB   249.19 (+1.68%)
AMZN   3,328.89 (+4.03%)
NVDA   427.95 (+2.09%)
CGC   17.92 (+2.87%)
BABA   260.61 (-0.15%)
MU   51.01 (+0.61%)
TSLA   1,757.84 (+13.80%)
AMD   56.72 (+1.50%)
T   29.83 (-1.00%)
F   6.11 (+0.16%)
DIS   119.68 (+0.28%)
NFLX   569.73 (+3.83%)
BAC   24.00 (-0.08%)
BA   175.46 (-1.67%)
AAPL   399.12 (+4.02%)
MSFT   215.45 (+0.83%)
FB   249.19 (+1.68%)
AMZN   3,328.89 (+4.03%)
NVDA   427.95 (+2.09%)
CGC   17.92 (+2.87%)
BABA   260.61 (-0.15%)
MU   51.01 (+0.61%)
TSLA   1,757.84 (+13.80%)
AMD   56.72 (+1.50%)
T   29.83 (-1.00%)
F   6.11 (+0.16%)
DIS   119.68 (+0.28%)
NFLX   569.73 (+3.83%)
BAC   24.00 (-0.08%)
BA   175.46 (-1.67%)
AAPL   399.12 (+4.02%)
MSFT   215.45 (+0.83%)
FB   249.19 (+1.68%)
AMZN   3,328.89 (+4.03%)
NVDA   427.95 (+2.09%)
CGC   17.92 (+2.87%)
BABA   260.61 (-0.15%)
MU   51.01 (+0.61%)
TSLA   1,757.84 (+13.80%)
AMD   56.72 (+1.50%)
T   29.83 (-1.00%)
F   6.11 (+0.16%)
DIS   119.68 (+0.28%)
NFLX   569.73 (+3.83%)
BAC   24.00 (-0.08%)
BA   175.46 (-1.67%)
Log in

NASDAQ:SWAVShockwave Medical Stock Price, Forecast & News

$43.55
+0.34 (+0.79 %)
(As of 07/13/2020 11:35 AM ET)
Add
Compare
Today's Range
$43.01
Now: $43.55
$43.59
50-Day Range
$43.55
MA: $45.52
$47.68
52-Week Range
$22.01
Now: $43.55
$54.51
Volume5,612 shs
Average Volume527,718 shs
Market Capitalization$1.39 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.82
ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.26 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SWAV
CUSIPN/A
CIKN/A
Phone510-279-4262

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$42.93 million
Book Value$6.81 per share

Profitability

Net Income$-51,110,000.00
Net Margins-112.25%

Miscellaneous

Employees162
Market Cap$1.39 billion
Next Earnings Date8/3/2020 (Estimated)
OptionableNot Optionable

Receive SWAV News and Ratings via Email

Sign-up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter.

Shockwave Medical (NASDAQ:SWAV) Frequently Asked Questions

How has Shockwave Medical's stock been impacted by COVID-19 (Coronavirus)?

Shockwave Medical's stock was trading at $34.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SWAV stock has increased by 26.5% and is now trading at $43.55. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Shockwave Medical?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Shockwave Medical.

When is Shockwave Medical's next earnings date?

Shockwave Medical is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Shockwave Medical.

How were Shockwave Medical's earnings last quarter?

Shockwave Medical Inc (NASDAQ:SWAV) issued its earnings results on Tuesday, May, 12th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by $0.10. The business had revenue of $15.20 million for the quarter, compared to the consensus estimate of $14.17 million. Shockwave Medical had a negative net margin of 112.25% and a negative return on equity of 38.18%. The company's revenue was up 109.1% compared to the same quarter last year. During the same period last year, the business posted ($1.37) earnings per share. View Shockwave Medical's earnings history.

What price target have analysts set for SWAV?

7 equities research analysts have issued 12 month target prices for Shockwave Medical's shares. Their forecasts range from $23.00 to $54.00. On average, they anticipate Shockwave Medical's share price to reach $44.86 in the next twelve months. This suggests a possible upside of 3.0% from the stock's current price. View analysts' price targets for Shockwave Medical.

Has Shockwave Medical been receiving favorable news coverage?

News coverage about SWAV stock has been trending very negative on Monday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Shockwave Medical earned a media sentiment score of -3.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Shockwave Medical.

Are investors shorting Shockwave Medical?

Shockwave Medical saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 3,850,000 shares, a drop of 5.6% from the June 15th total of 4,080,000 shares. Based on an average daily trading volume, of 412,900 shares, the short-interest ratio is currently 9.3 days. Currently, 14.8% of the company's shares are short sold. View Shockwave Medical's Current Options Chain.

Who are some of Shockwave Medical's key competitors?

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), salesforce.com (CRM), Alibaba Group (BABA), Walt Disney (DIS), Trade Desk (TTD), Roku (ROKU), Paypal (PYPL), Square (SQ), Twilio (TWLO) and Shopify (SHOP).

Who are Shockwave Medical's key executives?

Shockwave Medical's management team includes the following people:
  • Mr. Douglas E. Godshall, CEO, Pres & Director (Age 54)
  • Mr. Daniel Puckett, CFO & Sec. (Age 55)
  • Mr. Isaac Zacharias, Chief Commercial Officer (Age 44)
  • Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 52)
  • Mr. John M. Adams, Co-Founder and Technical Advisor (Age 72)

When did Shockwave Medical IPO?

(SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is Shockwave Medical's stock symbol?

Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."

How do I buy shares of Shockwave Medical?

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Shockwave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $43.55.

How big of a company is Shockwave Medical?

Shockwave Medical has a market capitalization of $1.39 billion and generates $42.93 million in revenue each year. The company earns $-51,110,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis. Shockwave Medical employs 162 workers across the globe.

What is Shockwave Medical's official website?

The official website for Shockwave Medical is www.shockwavemedical.com.

How can I contact Shockwave Medical?

Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at 510-279-4262 or via email at [email protected]

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.